Repurposing loratadine to induce ferroptosis and overcome multidrug resistance: preclinical evidence in KB-V-1 cells - Top-Institutions - MDSpire

Repurposing loratadine to induce ferroptosis and overcome multidrug resistance: preclinical evidence in KB-V-1 cells

  • By

  • Nicholas Cook

  • Xin Li

  • Nathan J. Bowen

  • Alira Danaher

  • MaKayla Thomas

  • Saani Alhassan

  • Briah Arms

  • Daqing Wu

  • June 17, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Emory University
    Emory University

    Atlanta, Georgia

    Key Differentiators

    • Oncology

  • #2

    National Cancer Institute
    National Cancer Institute

    Bethesda, Maryland

    Key Differentiators

    • Oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

Original Source(s)

Repurposing loratadine to induce ferroptosis and overcome multidrug resistance: preclinical evidence in KB-V-1 cells

  • by Nicholas Cook, Xin Li, Nathan J. Bowen, Alira Danaher, MaKayla Thomas, Saani Alhassan, Briah Arms, Daqing Wu

  • June 17, 2026

Related Content

CT-based radiomics improves survival prediction in colorectal liver metastases: beyond clinical scores

Epstein–Barr virus-driven immunosuppression in nasopharyngeal carcinoma: a comprehensive review of viral mechanisms, spatial tumor ecosystems, and precision therapeutics

Artificial intelligence for biomarker prediction in gastric cancer: from histopathology to multimodal integration